RE:RE:RE:New Bloom Burton analyst reportYes, I think it is. All was around Valeant,2 questions: business model and fraud.
It is almost sure that there is not fraud there, and the business model is legal. If they want to frame the game , they will change the law and Valeant will adapt the business.
They have nothing else so material on Valeant to keep all health industry down.
TheRock07 wrote: Thank you for that report whose target is close to $95 per share.
This specialized shorting of Canadian listed pharmas is now at an end.
Onwards and upwards to $100 +